Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy
Briefings in Bioinformatics · 22.11.2024 · 26 (1)
DOI: 10.1093/bib/bbae625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 04.12.2024. Verfasst von Long Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Technology, Harbin Institute of Technology, West DaZhi Street, 150001 Harbin, China. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, King Abdullah University of Science and Technology.
Abstract (Originalsprache)
Accurate prediction of binding between human leukocyte antigen (HLA) class I molecules and antigenic peptide segments is a challenging task and a key bottleneck in personalized immunotherapy for cancer. Although existing prediction tools have demonstrated significant results using established datasets, most can only predict the binding affinity of antigenic peptides to HLA and do not enable the immunogenic interpretation of new antigenic epitopes. This limitation results from the training data for the computational models relying heavily on a large amount of peptide-HLA (pHLA) eluting ligand data, in which most of the candidate epitopes lack immunogenicity. Here, we propose an adaptive immunogenicity prediction model, named MHLAPre, which is trained on the large-scale MS-derived HLA I eluted ligandome (mostly presented by epitopes) that are immunogenic. Allele-specific and pan-allelic prediction models are also provided for endogenous peptide presentation. Using a meta-learning strategy, MHLAPre rapidly assessed HLA class I peptide affinities across the whole pHLA pairs and accurately identified tumor-associated endogenous antigens. During the process of adaptive immune response of T-cells, pHLA-specific binding in the antigen presentation is only a pre-task for CD8+ T-cell recognition. The key factor in activating the immune response is the interaction between pHLA complexes and T-cell receptors (TCRs). Therefore, we performed transfer learning on the pHLA model using the pHLA-TCR dataset. In pHLA binding task, MHLAPre demonstrated significant improvement in identifying neoepitope immunogenicity compared with five state-of-the-art models, proving its effectiveness and robustness. After transfer learning of the pHLA-TCR data, MHLAPre also exhibited relatively superior performance in revealing the mechanism of immunotherapy. MHLAPre is a powerful tool to identify neoepitopes that can interact with TCR and induce immune responses. We believe that the proposed method will greatly contribute to clinical immunotherapy, such as anti-tumor immunity, tumor-specific T-cell engineering, and personalized tumor vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Computer Science and Technology, Harbin Institute of Technology, West DaZhi Street, 150001 Harbin, China.
- School of Medicine and Health, Harbin Institute of Technology, Yikuang Street, 150000 Harbin, China.
- College of Computer and Control Engineering, Northeast Forestry University, Hexing Road, 150040 Harbin, China.
- School of Computer Science and Technology, Heilongjiang University, Xuefu Road, 150080 Harbin, China.
- Postdoctoral Program of Heilongjiang Hengxun Technology Co., Ltd., Xuefu Road, 150090 Harbin, China.
- Shandong Hengxun Technology Co., Ltd., Miaoling Road, 266100 Qingdao, China.
ORCID-Profile: Long Xu, Qiang Yang, Weihe Dong, Xiaokun Li, Kuanquan Wang, Xianyu Zhang, Gongning Luo, Xin Gao, Guohua Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- King Abdullah University of Science and Technology
- Office of Research Administration
- Center of Excellence for Smart Health
- Center of Excellence on Generative AI
Zitieren
APA
Xu, L., Yang, Q., Dong, W., Li, X., Wang, K., Dong, S., Zhang, X., Yang, T., Luo, G., Liao, X., Gao, X., & Wang, G. (2024). Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy. Briefings in Bioinformatics, 26(1). https://doi.org/10.1093/bib/bbae625
Vancouver
Xu L, Yang Q, Dong W, Li X, Wang K, Dong S, et al. Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy. Briefings in Bioinformatics. 2024;26(1). doi:10.1093/bib/bbae625
BibTeX
@article{Xu2024,
author = {Xu, Long and Yang, Qiang and Dong, Weihe and Li, Xiaokun and Wang, Kuanquan and Dong, Suyu and Zhang, Xianyu and Yang, Tiansong and Luo, Gongning and Liao, Xingyu and Gao, Xin and Wang, Guohua},
title = {Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {26},
number = {1},
doi = {10.1093/bib/bbae625}
}
EUVIMED